Balentine LLC increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 7.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,780 shares of the healthcare conglomerate’s stock after acquiring an additional 258 shares during the period. Balentine LLC’s holdings in UnitedHealth Group were worth $740,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC boosted its position in UnitedHealth Group by 291.7% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 9,114 shares of the healthcare conglomerate’s stock valued at $1,785,000 after buying an additional 6,787 shares during the last quarter. Beacon Investment Advisory Services Inc. boosted its position in UnitedHealth Group by 4,073.1% in the 3rd quarter. Beacon Investment Advisory Services Inc. now owns 48,784 shares of the healthcare conglomerate’s stock valued at $9,555,000 after buying an additional 47,615 shares during the last quarter. Foyston Gordon & Payne Inc boosted its position in shares of UnitedHealth Group by 542.7% in the 3rd quarter. Foyston Gordon & Payne Inc now owns 146,712 shares of the healthcare conglomerate’s stock worth $28,734,000 after purchasing an additional 123,886 shares during the last quarter. Highbridge Capital Management LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $791,000. Finally, Bank of Nova Scotia Trust Co. boosted its position in shares of UnitedHealth Group by 22.3% in the 3rd quarter. Bank of Nova Scotia Trust Co. now owns 2,568 shares of the healthcare conglomerate’s stock worth $503,000 after purchasing an additional 468 shares during the last quarter. Institutional investors and hedge funds own 86.24% of the company’s stock.

In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kenneth Irwin Shine sold 198 shares of UnitedHealth Group stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the sale, the director now directly owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. Insiders have sold a total of 53,853 shares of company stock worth $12,358,508 in the last ninety days. 0.89% of the stock is currently owned by company insiders.

Several research firms have recently issued reports on UNH. Leerink Swann restated a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Cantor Fitzgerald raised their price target on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Oppenheimer raised their price target on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Wells Fargo & Co restated an “outperform” rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Finally, Citigroup raised their price target on UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $243.22.

Shares of UnitedHealth Group Inc (NYSE:UNH) opened at $225.82 on Thursday. The company has a market capitalization of $218,830.00, a price-to-earnings ratio of 21.08, a P/E/G ratio of 1.28 and a beta of 0.70. UnitedHealth Group Inc has a 12 month low of $156.49 and a 12 month high of $250.79. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm’s revenue was up 9.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.11 EPS. analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.

WARNING: “UnitedHealth Group Inc (UNH) Shares Bought by Balentine LLC” was posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.watchlistnews.com/unitedhealth-group-inc-unh-shares-bought-by-balentine-llc/1851594.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.